VMP 42043011000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Terazosin 10mg tablets
BNF code 0205040V0AAADAD
Virtual Therapeutic Moiety Terazosin
Date identifier became valid 7 Jul 2023
Previous product identifier 318777001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Terazosin hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 387068008
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Hytrin 10mg tablets (Advanz Pharma)
Terazosin 10mg tablets (A A H Pharmaceuticals Ltd)
Terazosin 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Terazosin 10mg tablets (Medihealth (Northern) Ltd)
Terazosin 10mg tablets (Medley Pharma Ltd)
Terazosin 10mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Terazosin 10mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback